F.D.A. Approves Drug to Treat Pain Without Opioid Effects
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug Administration approved a new medication Thursday to treat pain from an injury or surgery. It is expensive, with a list price of $15.50 per pill. But unlike opioid pain medicines, it cannot become addictive.
In his first confirmation hearing, Robert F. Kennedy Jr. tried to distance himself from his past statements on abortion and ...
As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...
A former executive of a global pharmaceutical company in Boston was sentenced Thursday for earning more than $250,000 through ...
The Trump administration’s Centers for Medicare and Medicaid Services (CMS) has signaled that it will be revamping the ...
Teva Pharmaceutical's Q4 2024 results were strong, but 2025 guidance underwhelmed, causing a sharp stock sell-off. See why I ...
Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
Weight-loss drugs are transforming health care and Wall Street, but exciting prospects don’t necessarily mean a company is a good investment.
The program, called 340b, allows eligible safety net providers to purchase drugs at deeply discounted prices, then reinvest ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback